Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000581 · ClinicalTrials.gov registry record · NA

Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries

A NA study, sponsored by Roswell Park Cancer Institute.

Terminated
Registry status
NA
Development phase
17
Enrollment target

NCT04000581: Clinical Trial NA study, sponsored by Roswell Park Cancer Institute.

NCT04000581 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000581, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.

TERMINATED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

This trial studies the impact of early mobility tracked with a 3-dimensional (3D) motion tracking technology (XSENS) on post-surgery recovery in patients undergoing oncologic surgeries. Xsens uses wireless measurements which could be used in clinical settings to objectively measure movement patterns (the joint range of movement and the distance of movement) during functional activities. Post-surgery mobility tracking may help doctors to identify the minimum required level of mobility after inpatient oncologic surgeries to enhance early post-surgery recovery and decrease early post-surgery complications.

Primary Outcome

changes in mobility (as measured by average velocity of pelvis) from baseline to discharge are compared between groups using a one-sided, two-sample t-test.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Physical Activity

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2019-05-31
Est. Completion 2020-04-10
Phase NA
Roswell Park Cancer Institute

365 total trials

Why NCT04000581 stopped before completion

NCT04000581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT04000581 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04000581 about?

NCT04000581 is a clinical study titled "Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries". This trial studies the impact of early mobility tracked with a 3-dimensional (3D) motion tracking technology (XSENS) on post-surgery recovery in patients undergoing oncologic surgeries. Xsens uses wireless measurements which could be used in clinical settings to objectively measure movement patterns...

What is the current status of trial NCT04000581?

This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2019-05-31. Estimated completion is 2020-04-10.

What interventions are being tested in trial NCT04000581?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Physical Activity (OTHER).

Who is sponsoring clinical trial NCT04000581?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04000581's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04000581, the US trial registry maintained by the National Library of Medicine. NCT04000581 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.